You just read:

Amgen/Novartis' Aimovig Label Revision and Teva's Ajovy Autoinjector Delay Clear the Way for Continued Growth of Eli Lilly's Emgality in the US Migraine Prevention Market, According to Spherix Global Insights

News provided by

Spherix Global Insights

Dec 18, 2019, 08:00 ET